These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4958387)

  • 21. The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece.
    Economidou J; Constantoulakis M; Augustaki O; Taylor PE; Zuckerman AJ; Baines PM; Bryceson MA
    Vox Sang; 1970; 19(3):401-3. PubMed ID: 4993791
    [No Abstract]   [Full Text] [Related]  

  • 22. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand.
    Laosombat V; Pornpatkul M; Wongchanchailert M; Worachat K; Wiriyasatienku A
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):149-53. PubMed ID: 9322298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum lipids and their modifications after blood transfusion in polytransfused beta-thalassemic patients.
    Leonardi S; Colianni R; Fischer A; Curreri R; Di Gregorio F; Pizzarelli G; Musumeci S
    Haematologica; 1988; 73(4):269-71. PubMed ID: 3139529
    [No Abstract]   [Full Text] [Related]  

  • 24. Intensive transfusion therapy in thalassemia major.
    Beard ME; Necheles TF; Allen DM
    Pediatrics; 1967 Nov; 40(5):911-5. PubMed ID: 6075668
    [No Abstract]   [Full Text] [Related]  

  • 25. [Auxological studies of 50 children with beta-thalassemia major].
    Agnello D; Malizia R; Scalisi D; Pitruzzella E; Masseria R
    Pediatria (Napoli); 1981; 89(2):207-17. PubMed ID: 7312490
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fetal hemoglobin in the follow-up of homozygous beta-thalassemia in blood transfusion treatment].
    Ferrara M; Ponte G; Esposito L
    Pediatria (Napoli); 1980 Dec; 88(4):541-8. PubMed ID: 6170042
    [No Abstract]   [Full Text] [Related]  

  • 27. [Classification of anti-Gm antibodies as 7S or 19S immunoglobulins in children with thalassemia treated with multiple transfusions].
    Vierucci A; Varone D; Borgatti L; Dettori M
    Boll Soc Ital Biol Sper; 1965 Feb; 41(3):127-30. PubMed ID: 5875550
    [No Abstract]   [Full Text] [Related]  

  • 28. A prospective study on the use of leucocyte-filters in reducing blood transfusion reactions in multi-transfused thalassemic children.
    Tan KK; Lee WS; Liaw LC; Oh A
    Singapore Med J; 1993 Apr; 34(2):109-11. PubMed ID: 8266145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bloodless evaluation of cardiac morphological parameters in hypertransfused thalassemic patients. Their course throughout time].
    Cassone R; Digilio G; Maugeri B; Leone G; Moroni C
    Minerva Cardioangiol; 1988; 36(1-2):25-30. PubMed ID: 2968526
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1981 Sep; 89(3):479-92. PubMed ID: 7346759
    [No Abstract]   [Full Text] [Related]  

  • 31. Post transfusion purpura in a thalassemic child.
    Kashyap R; Venkatesh S; Choudhry VP
    Indian Pediatr; 1997 Mar; 34(3):246-7. PubMed ID: 9282495
    [No Abstract]   [Full Text] [Related]  

  • 32. [PRESENCE OF ANTI-GAMMAGLOBULIN FACTORS OF GM GROUPS IN POLYTRANSFUSED CHILDREN AFFECTED BY COOLEY'S DISEASE. AN EXAMPLE OF ISO-IMMUNIZATION IN THE SPHERE OF PLASMATIC GROUPS].
    VIERUCCI A; VARONE D; BORGATTI L; DETTORI M
    Riv Clin Pediatr; 1964 Mar; 73():165-76. PubMed ID: 14202000
    [No Abstract]   [Full Text] [Related]  

  • 33. The management of beta-thalassemia in an urban district hospital.
    Lyn PC; Teh HC; Mulvey RF
    Med J Malaysia; 1985 Mar; 40(1):3-10. PubMed ID: 3831730
    [No Abstract]   [Full Text] [Related]  

  • 34. TT virus infection in healthy children, children after blood transfusion, and children with non-A to E hepatitis or other liver diseases in Taiwan.
    Hsu HY; Ni YH; Chen HL; Kao JH; Chang MH
    J Med Virol; 2003 Jan; 69(1):66-71. PubMed ID: 12436479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum IgE in polytransfused thalassemic patients.
    La Rosa M; Pavone L; Musumeci S; Mollica F; Ronchetti R
    Vox Sang; 1983; 45(5):384-8. PubMed ID: 6636660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension posttransfusion in Thai thalassemic children: early detection and management.
    Tanphaichitr VS; Suvatte V; Mahasandana C; Tuchinda S
    Birth Defects Orig Artic Ser; 1988; 23(5B):251-5. PubMed ID: 3390550
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapy of HBsAg-negative chronic active hepatitis in transfusion-dependent thalassemia major.
    De Virgiliis S; Argiolu F; Rais M; Cossu P; Toccafondi C; Sanna G; Cornacchia G; Nucaro A; Ferreli A; Cao A
    Birth Defects Orig Artic Ser; 1982; 18(7):355-60. PubMed ID: 6819018
    [No Abstract]   [Full Text] [Related]  

  • 38. [Leukocytic antibodies and possible transfusion complications in polytransfused patients].
    CUTRERA A
    Riv Ostet Ginecol; 1959 Jul; 14():466-9. PubMed ID: 13813456
    [No Abstract]   [Full Text] [Related]  

  • 39. Frozen red blood cell transfusion in patients with Cooley's disease.
    Avanzi G; Bacigalupo A; Strada P; Melevendi C; Traverso T; Adami R; Soldà AM; Reali G
    Haematologica; 1983; 68(5):646-55. PubMed ID: 6416942
    [No Abstract]   [Full Text] [Related]  

  • 40. [Aspects of hemotherapy in Cooley's anemias].
    Marletta J; Bugnard ER; Mitelman HR
    Arch Argent Pediatr; 1968; 66(4):159-63. PubMed ID: 5734717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.